Magnevist was approved in 1988 by the FDA to “….facilitate the visualization of lesions and abnormal vascularity ….” The pharmaceutical was intended, in other words, for the diagnosis…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.